NOKSIPZA
DEAD

Serial Number

79205069

Owner

Green Cross Holdings Corporation

Attorney

Yoon S. Ham

Filing Date

Jan 17, 2017

Add to watchlist:

No watchlists yet
View on USPTO

NOKSIPZA Trademark

Serial Number: 79205069 • Registration: 5319606

NOKSIPZA is a trademark filed by Green Cross Holdings Corporation on January 17, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Green Cross Holdings Corporation (24 trademarks)

107, Ihyeon-ro 30beon-gil, Giheung-gu,
Yongin-si, Gyeonggi-do 16924 , KR

Entity Type: 03

Trademark Details

Filing Date

January 17, 2017

Registration Date

October 31, 2017

Published for Opposition

August 15, 2017

Cancellation Date

May 17, 2024

Goods & Services

Pharmaceutical agents affecting sensory organs; thyroid and para-thyroid hormone preparations; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; vaccines against flu; veterinary vaccines; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the treatment of the immune system by regulating it; virucides; vaccine preparations; adrenal hormone preparations; pharmaceutical preparations for use in gynecology; pharmaceutical preparations for use in urology; vitamin tablets; pharmaceutical preparations for wounds; cellular function activating agents for medical purposes; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; veterinary substances and preparations, namely, antioxidants; veterinary diagnostic reagents for use in veterinary genetic testing; pharmaceutical preparations for the treatment of cardiovascular disease; ophthalmic preparations; ophthalmologic preparations; eye drops; pharmaceutical preparations for treating allergies; pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical agents for epidermis; sanitary sterilising preparations; medicines for the treatment of gastrointestinal diseases; medicated mouth care and treatment preparations; parasiticides for medical use; diagnostic preparations for medical or veterinary purposes; cleansing solutions for medical use; cardiovascular agents for medical purposes; reagents for medical use; reagents for use in medical genetic testing; hemostatics for medical purposes; antibacterial substances for medical purposes; diuretics; insulin; human vaccine preparations; general anesthetics; pharmaceutical preparations for the treatment of auto-immune diseases; multivitamin preparations; pharmaceutical preparations acting on the central nervous system; styptic pencils for medical purposes; pharmaceutical preparations for treating asthma; pharmaceutical solutions used in dialysis; penicillin preparations; antimicrobials for dermatologic use; pharmaceutical preparations for treating skin disorders; contraceptive preparations; antihypertensives; anti-diabetic pharmaceuticals; antitoxins; antivirals; antiarrhythmic agents; antibiotic preparations; anti-cancer preparations; anticoagulants; tumor suppressing agents; antifungal preparations; anti-dermoinfectives; antidotes; antipyretic analgesics; vasoconstrictors; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; mixed antibiotic preparations; mixed hormone preparations; chemotherapeutics; pharmaceutical preparations for use in discouraging the smoking habit, namely, smoking cessation preparations

Retail and wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; advertising services relating to pharmaceutical products; advertising relating to pharmaceutical products and in-vivo imaging products

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Apr 26, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 8, 2025 INTS
INVALIDATION PROCESSED
Apr 8, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 18, 2025 INTR
CANCELLED SECTION 71
May 17, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 31, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 13, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 12, 2018 FICS
FINAL DISPOSITION PROCESSED
Feb 12, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 31, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 31, 2017 R.PR
NOTIFICATION PROCESSED BY IB
Aug 18, 2017 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 15, 2017 NPUB
PUBLISHED FOR OPPOSITION
Aug 15, 2017 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 2, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 2, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 26, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 10, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 5, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 5, 2017 CRFA
ASSIGNED TO LIE
Jun 29, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 1, 2017 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 31, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 31, 2017 REAP
REFUSAL PROCESSED BY IB
May 5, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 19, 2017 RFCS
REFUSAL PROCESSED BY MPU
Apr 19, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Apr 18, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 16, 2017 RFCR
NON-FINAL ACTION WRITTEN
Apr 15, 2017 CNRT
ASSIGNED TO EXAMINER
Apr 15, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 14, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 13, 2017 REPR